Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Monopar Therapeutics | MNPR | Aug 30, 2024 | 2.39 | +0.84 |
Monro | MNRO | Aug 30, 2024 | 27.09 | +2.00 |
Monroe Capital | MRCC | Aug 30, 2024 | 7.79 | +0.39 |
Monster Beverage | MNST | Aug 30, 2024 | 47.13 | +0.28 |
Montana Technologies A | AIRJ | Aug 30, 2024 | 5.58 | +5.68 |
Montauk Renewables | MNTK | Aug 30, 2024 | 4.69 | +1.52 |
Monte Rosa Therapeutics | GLUE | Aug 30, 2024 | 6.17 | -3.44 |
Montrose Environmental Group | MEG | Aug 30, 2024 | 32.90 | +1.14 |
Moodys | MCO | Aug 30, 2024 | 487.74 | +0.97 |
Moog A | MOG-A | Aug 30, 2024 | 197.40 | +1.55 |
Moog B | MOG-B | Aug 30, 2024 | 195.46 | 0.00 |
Moolec Science | MLEC | Aug 30, 2024 | 0.87 | +0.01 |
MoonLake Immunotherapeutics | MLTX | Aug 30, 2024 | 46.79 | -1.45 |
Morgan Stanley | MS | Aug 30, 2024 | 103.61 | +0.98 |
Morgan Stanley China A Share Fund | CAF | Aug 30, 2024 | 11.85 | +0.25 |
Morgan Stanley Direct Lending Fund | MSDL | Aug 30, 2024 | 20.66 | -0.05 |
Morgan Stanley Emerging Markets Debt Fund | MSD | Aug 30, 2024 | 7.67 | +0.07 |
Morgan Stanley Emerging Markets Domestic Debt Fund | EDD | Aug 30, 2024 | 4.96 | +0.40 |
Morgan Stanley FXDFR Pref | MS-K | Aug 30, 2024 | 24.78 | -0.20 |
Morgan Stanley India Investment Fund | IIF | Aug 30, 2024 | 27.88 | +0.36 |
Morgan Stanley Pref A | MS-A | Aug 30, 2024 | 22.21 | -0.85 |
Morgan Stanley Pref E | MS-E | Aug 30, 2024 | 25.32 | +0.16 |
Morgan Stanley Pref F | MS-F | Aug 30, 2024 | 25.31 | +0.16 |
Morgan Stanley Pref I | MS-I | Aug 30, 2024 | 25.14 | -0.16 |
Morgan Stanley Pref L | MS-L | Aug 30, 2024 | 22.53 | -0.31 |
Morgan Stanley Pref O | MS-O | Aug 30, 2024 | 19.50 | -0.10 |
Morgan Stanley Pref P | MS-P | Aug 30, 2024 | 25.73 | -0.46 |
Morgan Stanley Pref Q | MS-Q | Aug 30, 2024 | 26.75 | 0.00 |
Moringa Acquisition Units | MACAU | Aug 30, 2024 | 9.90 | 0.00 |
Morningstar | MORN | Aug 30, 2024 | 313.77 | +0.70 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.